• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威未经治疗的幽门螺杆菌患者对甲硝唑和其他抗菌药物的耐药率。

Resistance rates of metronidazole and other antibacterials in Helicobacter pylori from previously untreated patients in Norway.

机构信息

Department of Microbiology, Østfold Hospital Trust, Fredrikstad, Norway.

出版信息

APMIS. 2013 Apr;121(4):353-8. doi: 10.1111/apm.12009. Epub 2012 Oct 22.

DOI:10.1111/apm.12009
PMID:23083455
Abstract

The aim of the study was to describe the antimicrobial resistance rate of Helicobacter pylori isolated from previously untreated patients in Norway, including the application of two different methods for the determination of metronidazole susceptibility. Altogether 102 isolates obtained in 2008 and 2009 from previously untreated patients suspected of H. pylori related disease, were examined applying a standardized European study protocol. The activity of amoxicillin, tetracycline, clarithromycin, metronidazole, rifabutin and levofloxacin was recorded after an incubation period of 72-96 h in a microaerobic atmosphere. Strains resistant to metronidazole were re-examined for metronidazole resistance applying anaerobic conditions for the first 24 h. None of the isolates were resistant to amoxicillin or tetracycline, whereas 5, 9% were resistant to clarithromycin and 22, 5% resistant to metronidazole tested conventionally. Applying local standards the metronidazole resistance rate fell to 7, 8%, highlighting the importance of the methodology applied for metronidazole susceptibility testing.

摘要

本研究旨在描述 2008 年至 2009 年间,挪威未经治疗的幽门螺杆菌分离株的抗生素耐药率,包括两种不同的甲硝唑药敏检测方法的应用。根据标准化的欧洲研究方案,对怀疑与幽门螺杆菌相关疾病的 102 例未经治疗的患者中分离出的幽门螺杆菌进行检测。在微需氧条件下孵育 72-96 小时后,记录阿莫西林、四环素、克拉霉素、甲硝唑、利福布汀和左氧氟沙星的活性。对甲硝唑耐药的菌株,先在厌氧条件下培养 24 小时,然后重新检测甲硝唑耐药性。没有分离株对阿莫西林或四环素耐药,而 5.9%的分离株对克拉霉素耐药,22.5%的分离株对常规检测的甲硝唑耐药。采用当地标准,甲硝唑耐药率下降至 7.8%,突出了甲硝唑药敏检测方法的重要性。

相似文献

1
Resistance rates of metronidazole and other antibacterials in Helicobacter pylori from previously untreated patients in Norway.挪威未经治疗的幽门螺杆菌患者对甲硝唑和其他抗菌药物的耐药率。
APMIS. 2013 Apr;121(4):353-8. doi: 10.1111/apm.12009. Epub 2012 Oct 22.
2
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.台湾东部幽门螺杆菌分离株的抗生素耐药率。
J Gastroenterol Hepatol. 2007 May;22(5):720-3. doi: 10.1111/j.1440-1746.2006.04743.x.
3
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.1999 - 2003年阿拉斯加对阿拉斯加原住民幽门螺杆菌分离株的抗菌药物耐药性进行哨点监测。
Helicobacter. 2006 Dec;11(6):581-8. doi: 10.1111/j.1523-5378.2006.00462.x.
4
[Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].[36株青少年幽门螺杆菌的耐药性]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Mar;11(3):210-2.
5
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.1995 - 2001年日本东京胃窦和胃体幽门螺杆菌分离株对克拉霉素、阿莫西林和甲硝唑的敏感性
Clin Microbiol Infect. 2005 Apr;11(4):307-11. doi: 10.1111/j.1469-0691.2005.01099.x.
6
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.孟加拉国分离出的幽门螺杆菌菌株的抗菌药敏性。
J Clin Microbiol. 2004 Oct;42(10):4856-8. doi: 10.1128/JCM.42.10.4856-4858.2004.
7
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.克拉霉素和甲硝唑的高水平双重耐药以及左氧氟沙星对治疗失败患者幽门螺杆菌分离株的体外活性。
Int J Antimicrob Agents. 2004 Nov;24(5):433-8. doi: 10.1016/j.ijantimicag.2004.02.032.
8
Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt.从埃及儿童中分离出的幽门螺杆菌对甲硝唑普遍具有高水平原发性耐药。
J Clin Microbiol. 2004 Oct;42(10):4832-4. doi: 10.1128/JCM.42.10.4832-4834.2004.
9
Antibiotic resistance in Helicobacter pylori: is it a problem in New Zealand?幽门螺杆菌的抗生素耐药性:这在新西兰是个问题吗?
N Z Med J. 2004 Aug 20;117(1200):U1022.
10
Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children.来自伊朗成年人和儿童的幽门螺杆菌分离株的抗菌药物耐药性。
Arch Iran Med. 2006 Oct;9(4):308-14.

引用本文的文献

1
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.克拉霉素耐药分离株的流行率:系统评价和荟萃分析。
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.
2
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.治疗前后幽门螺杆菌对抗生素的耐药性:根除失败的发生率。
PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022.
3
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.
4
Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication.15 年后未能成功根除的幽门螺杆菌感染患者的临床特征。
PLoS One. 2020 Sep 23;15(9):e0238944. doi: 10.1371/journal.pone.0238944. eCollection 2020.
5
Importance of antimicrobial susceptibility testing for the management of eradication in infection.抗菌药物敏感性测试在 感染根除管理中的重要性。
World J Gastroenterol. 2017 Apr 28;23(16):2854-2869. doi: 10.3748/wjg.v23.i16.2854.
6
Antibiotic treatment for Helicobacter pylori: Is the end coming?幽门螺杆菌的抗生素治疗:终点将至?
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):183-98. doi: 10.4292/wjgpt.v6.i4.183.
7
Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.幽门螺杆菌抗生素耐药性的流行情况:近期文献综述
World J Methodol. 2015 Sep 26;5(3):164-74. doi: 10.5662/wjm.v5.i3.164.
8
Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?2007年至2014年幽门螺杆菌继发性抗生素耐药性的趋势:形势是否已转变?
J Clin Microbiol. 2015 Feb;53(2):522-7. doi: 10.1128/JCM.03001-14. Epub 2014 Nov 26.
9
How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?抗生素耐药性如何改变幽门螺杆菌的治疗:与地理位置有关?
World J Gastroenterol. 2013 Dec 7;19(45):8168-80. doi: 10.3748/wjg.v19.i45.8168.
10
Optimum duration of regimens for Helicobacter pylori eradication.幽门螺杆菌根除治疗方案的最佳疗程
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.